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In vivo studies have demonstrated that various treat-
ments of skin, e.g. , UV irradiation, topical corticoster-
oids, and tape-stripping, will temporarily deplete the 
epidermis of Langerhans cells (LC). Whether this loss 
represents simply a loss of cell surface markers unique 
to LC, or actual depletion of cells, is unknown. By de-
sign, normal human skin transplanted to the congeni-
tallY athymic (nude) mouse is a system devoid of circu-
lating precursors for human LC. Because LC have been 
shown to be of bone marrow origin, any depletion of 
these cells in this system should be permanent. Treat-
ments to deplete LC from human skin grafts on nude 
mice after grafting included: (a) large doses of UV ra-
diation (400 mJ/cm2 every 48 h, x 3), (b) potent high-
dose topical corticosteroids (2.5 mg betamethasone val-
erate/cm2 every day, x 5), (c) tape-stripping (x 20). 
Treatments before grafting included: (a) treating donor 
skin with 900 R of gamma irradiation, (b) complement 
fixing monoclonal antibody to Ia-like antigens of LC, 
followed by fresh complement, (c) monoclonal antibody 
conjugated to toxins. Quantitation of the number of LC 
was analyzed on control and treated epidermal sheets 
using immunodiagnostic reagents, anti-HLA-DR, and 
surface ectoenzymes, ATPase. 
Results show that both UV irradiation and topical 
corticosteroids reduce the number of LC by these anal-
yses. However, within 3 weeks, recovery to pretreat-
ment levels has occurred. X-irradiation and tape-strip-
ping were without effect. Despite evidence that the mon-
oclonal antibody, complement, and toxic systems were 
delivered to the LC within the epidermis, there is no 
evidence that these treatments resulted in a decrease in 
LC. It appears that LC are currently either long-lived 
or replaced locally from a proliferative pool and that 
certain cell membrane determinants of human LC are 
somewhat differentially sensitive to UV radiation and 
corticosteroids. 
The recent finding that LC have fea t ures of macrophages 
has stimulated a great deal of interest re lative to the role of LC 
in the normal structure and funct ion of the skin , especial ly 
fr om a n immunologic point of view [1-3]. Largely because of 
the affinity of LC for kerat inizing epit helia, it has been specu-
lated that LC have a role beyond the macrophage funct ion of 
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a nt ige n presentation-that of regulating ep idermal homeosta-
sis [1 ,4-7]. By design , normal human sk in transplanted to 
congeni tally athymic (nude) mice is a system t hat is devoid of 
circulating precursors for human LC; hence, any depletion 
should be permanent if LC are termi nally differentiated. T hus 
we felt a direct analysis of LC on epidermal homeostasis cou ld 
be made by studying human sk in with a fu ll complement of LC 
and t hen ~V i a depletion experiments with less t han a full com-
plement of LC. 
Using immunologic reagents spec ific for class II major his-
tocompatability antigen complex (MHC) antigens (Ia or !a-
like, DR in humans) of various strains and species, we have 
recent ly shown t hat LC of t he host nude mouse will not 
infil t rate xenografts of human or guinea pig sk in . In t hese 
situations t he donor LC persist for t he life of t he graft, this 
despite epidermal proliferation and t he absence of circulatinr.r 
precursors [8,9 ]. This suggested t hat LC are replenished l ocal!~ 
fro m epiderma l or dermal precursors, or t hat LC are loner- lived 
and further suggested that depletion of LC from humanbskin i~ 
plaus ible u ing t his system. 
A number of investigators have demonstrated t hat UV radia -
tion [10- 15], topical corticosteroids [10,16, 17], as well as tape-
stripp ing [18] will temporari ly deplete LC from t he skin in an 
in vivo setting. Simply holding sk in in vitro has been reported 
to dep lete t he number of LC (19]. Incubating epidermal cell 
suspensions with monoclona l a nt ibodies to t he specific class II 
MHC antige ns (la or Ia- like) for t hat species and t hen addinr.r 
fresh complement a lso appea rs to effectively deplete epidermai 
ce ll suspensions of LC in an in vitro setting [2,3,19]. 
The experiments presented here begin the probe of t he role 
of LC on ep iderma l homeostasis by addressing two basic ques-
tions. Do LC live for long periods of time in a milieu where the 
surrounding epidermal ce ll s a re dividing and being shed a nd 
where no circulating precurso rs for LC ex ist? Do LC lose t heir 
ma rkers in response to various stimuli and t hen regain t hem? 
Data show t hat LC are not. readi ly depleted, rather t hat markers 
of LC are either rapidly lost a nd regained or t hat LC or their 
precursors a re probably not termina lly differentiated. 
MATERIALS AND METHODS 
Animals/ Grafting Procedures/ Measurement of LC Density 
Pathogen-free congenitally athym ic (nude) mice on a BALB/ c (H-
2d) background were grafted with spli t-thickness skin grafts (STSG) 
(0.:3 mm) harvested from the thighs of organ donors or from discarded 
skin of healthy human subjects undergoing abdominoplasty or breast 
reduction. The STSG were harvested within 24 h of death or surgery 
with a Brown electrokeratome. 
As previously described, LC density of the epidermal sheets was 
quanti tated by stains for ATPase activity or monoclonal ant ibodies 
specific for host or donor l.a (9] . Monoclonal antibodies specific for [a 
antigens that were used in these studies included MK.D6, specific for 
an l-Ad determinant which is on the LC of the nude host (gift. of J. 
Kapp ler, National Jewish Hospital, Denver, Colorado); anti-HLA-DR, 
a mouse monoclonal antibody against human DR antigens, wh ich binds 
to the Ia-like antigens of human LC (Becton-Dick inson, Palo Alto 
Cali fornia); OKT-6, a mouse monoclonal antibody that binds to deter: 
minants on human LC and immature thymocytes (Ortho Diagnostics, 
Raritan, New ,Jersey); and HLA-AB (Bethesda Research Laboratories, 
Bethesda, Maryland), a mouse monoclonal antibody against human 
leukocyte class I anti gens which was used to distinguish human from 
mouse tissue. Analysis by immunonuorescent examination of epidermal 
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sheets reveals that the a nt ihuman reagents HLA -DR, OKT-6, and 
HLA -AB do not react with mouse t issue; li kewise, MK.D6 does not 
bind with human LC [9]. Optimal concent rations for the foregoing 
ant ibodies for visual ization of LC ranged from 1:10 to 1:400 of t he 
stock solu t ion, or was the co ncentration suggested by t he manufacturer. 
Prior to graftin g, a nd at various times a fter graftin g or t reatment, 
the expe ri menta l skin grafts were surgically removed in part or in tota l 
from t he mice and placed, dermal side down, in a solut ion of EDTA, 
as described by J uhlin and Shelley [20]. After incubation for 2 h at 
:JTC, the epidermal sheet was carefull y peeled from t he dermis a nd cut 
into 4 pieces (approximately 4 x 4 mm) , a nd the presence and density 
of epidermal LC analyzed as previously described [9]. Briefly, the 
number of ATPase-po it ive epidermal cells was determined as de-
scr ibed by Mackenzie and Squie r, by ra ndomly coun ting 20 fie lds at 
400X with an ocular grid of known area [21]. With these data, the 
number of LC per mm2 was calculated. Depending upon the source of 
the skin gra ft being investigated, specific monoclonal reagents were 
also used to qua li tatively a nd quan t itatively determine the number of 
epidermal LC. For this, a 4 x 4 mm section of t he epidermal sheet was 
br iefl y fi xed in cold acetone, rehydrated wit h phosphate-buffered saline 
(PBS), incubated for 16 h with t he test antibody, and washed exten-
sive ly with PBS. The presence of ti ssue-bound ant ibody to ta rget 
ant igen was assessed eit her by indirect immunofluorescence (fluores-
cein -conjugated goata ntimouse lgG; Cappel Laboratories, Westchester, 
Pennsylvan ia), or by t he indirect immunoperoxidase technique (Yec-
tastain ABC imm unoperoxidase-staining procedure and reagents; 
mouse lgG PK 4002 Kit, Vector Laboratories, Burl ingame, Californ ia ). 
1 ncubation with the secondary reagents was for 1 b at 4 •c; t his was 
fo llowed by extensive washing with PBS prior to mount ing in glycero l 
and examination with a Le itz microscope equipped with a regu lar as 
well as an epifluorescent li ght source. 
Met,hods to Alter LC Density 
X -irra.diation: STSG, wh ile suspended in complete media, were 
either sham treated or x- irradiated with 900 R (cesium source) prior to 
graft ing. At interva ls afte r grafting, the gra fts were analyzed for LC 
density as described above. 
Tape-st ripp1:ng: Mice with grafts of human STSG of 4 weeks duration 
were anesthet ized with ether prior to tape-stripping. Tape-stripping 
was confined to t he graft by pl ac in g a metal template over t he graft 
and carried out by repeatedly (20 t imes) applying and removing Scotch 
810 Magic T ransparen t Tape (19-mm wide, Commercial Tape Division/ 
3M, St.. Paul, Minnesota) . LC·density was determined 24 has well as 
I week a fter th is insult. Part of eac h specimen was also analyzed for 
epiderma l proliferation usi ng a p reviously described technique of puls-
ing a piece of the removed graft with [3H]thymidine [22]. Autoradi-
ographic a nalysis of grafts treated in t his way typically showed a 4- to 
5-fold increase in I"H]thymidin e incorporation into DNA of germinal 
epidermal ce ll s. 
Ultraviolet radiation: Experiments showed the amount of mid-range 
UV radiation (UVB) from our light source (Westinghouse FS 40, 
emission = 280- 380, peak at 313) needed to cause acute changes in LC; 
l os~ of dendritic processes within 24 h was 50- 100 mJ/cm 2. This 
quantitation was by radiometric analysis (In te rnational Light Research 
Radiometer, Newburyport, Massac husetts) . These experiments were 
aimed at deplet ing LC from the grafts; t herefore, even higher doses of 
UVB were used. While the animal was a nesthet ized (i.p. chloral hy-
drate) 400 mJ/cm' of UVB was de livered to the graft site using a bank 
of FS 40 bu lbs where the source-to-ta rget distance was 25 em. The 
surroundin g mouse skin was protected from UV radiation by a card-
board templ ate. Thi s dose of UVB was repeated at 48- h intervals, t imes 
3 (tota l dose of UVB = 1200 mJ /cm2/graft). Biopsies of the t reated 
sites were taken at specific time intervals and evaluated for LC density 
and morph ology. This dose of UVB to mouse skin leads to erythema 
a nd nec rosis. Howeve r, delivery of th is dose to the human skin gra ft 
did not effect a visible cha nge in skin morphology. 
Topical corticosteroids: Betamethasone va lerate (BY) and the lotion 
base used to make Valiso ne lotion was supplied to us through the 
courtesy of Sc hering Plough Co rporation, Pharmaceutical Research 
Division , Bloom fi eld, New J ersey. From these, 3 preparations were 
made: the lotion base, BY lotion 0.1.%, and BY lotion 1.0%. A prelim -
inary a nalys is of these reagents showed t hat de live ring 250 J.d of 0.1 % 
BY lotion to the gauze of a standard 1" banclaid, and immediate ly 
applying same to the gra ft and repeati ng this 1 day later, did effect a 
change in t he morphology and density of LC 24 h afte r the last 
app lication. For the experiments recorded herein, th is procedure was 
repeated every day for 5 days (total dose of BY lotion 0.1 % = 1.25 mg, 
and for U)% = 12.5 mg). LC density was evaluated at specified times 
after the last t reatment. These dosages of BY to the graft did not affect 
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LC density or morphology of the ears of t he expe rimental mouse, i.e., 
systemic absorp t ion was insufficien t to effect change throughout t he 
mouse. 
Depletion with monoclonal antibodies and toxin conjugates: Depletion 
of LC from STSG of 0.2-mm th ickness was carried out a fter: (a) it was 
dete rmined t hat a 1-h incubation of anti-HLA-DR at 1:40 followed by 
a 20-min incubation of a complement source (rabbit compleme nt, low 
tox icity at 1:4) wou ld kill 95% of test ce lls bearing human HLA-DR 
ant igens, Raji ce lls; (b) it was shown with immunof1uorescent tech-
niques that incubat ing these t hinner STSG wi th a 1:40 dilution of 
HLA-DR for 16 h at 4°C led to good visualization of LC (independent 
analysis of epidermal sheets for LC revealed the same number of LC 
with this technique); (c) it was shown, with antirabbit complemen t 
followed by secondary immunof1uorescent techniques, that t he low 
tox icity complement (1 :4) bound within 20 min to t he LC of the STSG 
previously incubated with anti-HLA-DR. (Incubating STSG with the 
low-tox icity complement source at 1:4 alone did not reveal binding of 
co mplement by LC.) 
These experiments were followed by experiments where t he thin 
STSG were incubated with HLA-DR at 1:10 for 16 h and with comple-
ment for an additional 4 h at 4 °C. The increased time (see above) was 
added to experimental protocol to ensure a n effect. These STSG were 
t hen either grafted immediately or held at 37' C with RPMI -1640, 10% 
FCS, and penicillin -streptomycin for 24 h prior to grafting. Biops ies 
were taken at 2 weeks, and LC morphology, density, type, etc. deter-
mined. 
Attempts to deplete LC were a lso carried out using the a lpha chain 
of ricin. This tox in, upon penetration into cells, is termina lly toxic 
secondary to its effec ts on t he in t racellul ar synthesis of protein. lt has 
been previously demonstrated t hat when the alpha chain of ricin was 
conjugated to a monoclonal a nt ibody specific to a n ant igen on a cell 
surface and then incubated in vit ro with target ce lls containing t hese 
a nt igens, specific cytotoxicity occurs [23,24 ]. The conjugation of alpha 
chain of ricin to anti-HLA-DR was through t he courtesy of t he labo-
rato ry of J. K apla n, P h.D. , Depa rtment of Pathology, University of 
Utah School of Medicine, using previously described techniques 
[23,24 ]. T hi s conjugate bound to DR-bearing Raj i cells and not to non-
OR-bearing contro l HeLa cells. A 24- h incubation with test a nd contro l 
cells showed only a 40% decrease in viabili ty with the highest concen-
tration tested, 1:2. Thus t his conjugate was abando ned as a system for 
deplet ion of LC. 
Whole-chain ricin conjugated to biotin (Vector Laboratories) was 
obtained, diluted 1:10, 1:100, a nd 1:1000 in RPM!. This conjugate was 
added with avidin, 0.3 mg/ml, diluted 1:100 in RPMI to Raji cells that 
had been preincubated for 1 h with biotinylated anti-HLA-DR. Binding 
of t he ricin -biotin conjugate was determ ined to be maximum at t he 
1:10 co ncent ration using rabbit a nti-ricin (donated by Marty Rechstei-
ner, Ph.D., Depart ment of Biology, University of Utah) and a subse-
quent second step with fluorescein -labeled goat a nt irabbit JgG. To 
prevent nonspecific binding by the beta chain of the whole-cha in ricin-
biotin conjugate, the reaction was carried out in the presence of 200 
mM lactate [25]. Th is toxin conjugate led to a pronounced decrease i11 
protein synthesis a nd cell viabili ty when added to Raji cells but not 
HeLa cells. This was t ime-dependent and greater t ha n that seen with 
the alpha ricin chain conjugate. The biotin-ricin conjugate (1:10) and 
avidin (1:100) were added to thin STSG previously incubated for 16 h 
with biotinylated HLA-DR. These t reated STSG were then held in 
vit ro for an addi t ional 48 h at 37•c or t ra nsplanted directly to the nude 
mice. Prior to t ransplantation , a sample of t he t ra nsplant was taken 
and t reated with t he anti -ricin and the necessary secondary reagents. 
This ana lysis revealed binding of a toxin complex to LC. 
RESULTS 
Recently our laboratory has s hown that host mouse LC do 
not infiltrate t he epidermis of huma n skin grafts on nude mice 
[9 ]. Beca use there a re no circulat ing hum a n LC in this system, 
the noti o n evolved that waiting might be an effective way to 
deplete LC. Accordingly, a study was initiated to determine the 
density of LC as a function of t ime fo llowi n g the orthotopic 
e ngraftment of human STSG to nude mice. These data are 
presented in Table I. The day 0 baseline va lues are take n from 
samples of t he STSG immediately prior to grafting. In these 
sampl es, the day 0 density did not vary s ignificantly , relative 
to t he a n atomic sites of donation-abdomen, thigh, and breast. 
The remaining data in Table I are from an analysis of at least 
2 grafts, at each time interval, from t he skin of abdominoplas-
t ies from 3 different patients. 
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TABLE I. Number of Langerhans cells us time in human skin grafts on. 
nude mice 
Mean no. or Langerhans cell s/ mm' ± SO 
Time n (range) 
ATPase Ia 
Day 0 8 770 ± 123 832 ± 178 
(655-1008) (625- 1150) 
Day 7 3 869 ± 209" 1100 ± 278" 
(711- 1006) (800- 1350) 
Day 21 3 1105 ± 520" 978 ± 447" 
(550- 1580) (510- 1400) 
Day 42 3 402 ± 218b 802 ± 114" 
(200-633) (700-925) 
Day 63 3 503 ± 118b 602 ± 184" 
(390-625) (400-760) 
a Values are not significant from the day 0 value for that marker of 
L C. 
b Values are significantly different, p < 0.05, (t-test of means) from 
the day 0 value for that marker of LC. 
Data demonstra te an insignificant initial increase in LC 
density by both assessments for the presence of LC, ATPase, 
and Ia- like antigen. These increases are followed by decreases 
in d e nsity, again of near equal magni tude for both markers. At 
9 weeks, the decrease is 28% less than baseline by analysis for 
the I a marker, a nd 35% for the ATPase marker, the later values 
showing low levels of significance, p < 0.05, (t-test of means). 
This prompted a th ird comparison; the same donor and same 
graft at base line, and at 6 and 9 weeks post grafting. Because 
of limited t issue, th is analysis employed on ly the Ia marker for 
t h e number of LC/ mm2 . These values are 625 at baseline, 782 
at 6 weeks, and 613 at 9 weeks. In a second case, these values 
are 730 at baseline, 813 at 6 weeks, and 580 at 9 weeks. This 
assessment, t he variations seen, and the limited data at 6 and 
9 weeks cause us to conclude that despite low-level significance 
at 6 and 9 weeks, for the ATPase values, t he LC density is 
bas ically unchanged over t he time period studied. It also causes 
u s to conclude t hat wa iting is not adequate for depleting LC 
from skin . 
Observations by other investigato rs show that x-irradiation 
[26 ,27], tape-stripping [18], or prolonged incubation [19] of 
s kin as an organ cu lture in vitro will deplete t he tissue of LC. 
T o determine the effect of these manipulat ions on our system, 
STSG from an abdominoplasty from one donor receives either 
900 R (ces ium source) or a sham t reatment prior to t ransplan-
tation to two groups of nude mice (4 per group). The baseline 
value for LC density, by analysis for Ia, after radiation, is 660/ 
mm 2 . At 3 weeks post grafting, the values are 268 ± 88 for t he 
group receiving 900 R, and 550 ± 54 for the group receiving t he 
sham treatment. No differences in LC densi ty, l a vs ATPase, 
and no infiltrat ion of mouse LC are noted in t hese experiments. 
Further experiments were not undertaken, as radiation at these 
and higher doses was felt to be unacceptable to the analysis of 
t h e question , which prompted t hese studies-the role of LC in 
epidermal homeostasis. 
Tape-stripping (X 20) of other human skin grafts from this 
do n o r 3 weeks after grafting shows a decrease in density in LC 
at 24 h wit h recovery to non -tape-strip values within 2 weeks. 
The number of LC 24 h after tape-stripping by ATPase analysis 
is 248 ± 220 vs controls at 550 ± 14, and by la analysis is 375 
± 530 vs contro ls at 515 ± 77. Tape-stripping skin which has 
been x-irradiated prior to t ransplantation on two mice also 
causes an apparent decrease at 24 h. However, wi thin 2 weeks, 
t h ese decreases are no longer present. This demonstra tes t hat 
900 R does not appear to affect t he abi li ty of LC to repopulate 
t h e s kin . 
Experiments have demonstrated a direct correlation between 
survivability of STSG when grafted and t he time they are held 
in vitro in complete media (RPMI 1640, penicillin and strep -
tom ycin and 10% fetal calf serum) , either at 37"C or at 4"C. In 
those STSG where t he density of LC decreases to less t han 
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30% of basel ine (e.g., STSG as an organ culture at 37"C for 8-
10 days) t he overall viabili ty of a gra ft is such t hat it does not 
survive transplantation. In t hose s it uations where holdino- the 
STSG does not lead to a decrease in viability upon en araft1~ e n t 
e.g., ~ "C for 7- 8 days, changes in LC morpho log';, (loss of 
dendnt1c processes) and density (up to a 50% decrease in 
number of LC) do occur. However, t he density and morphology 
of LC in t hese STSG are normal 3 weeks post o-raftin a. " 
UV radiat ion and topical corticosteroids have also been 
sho":n to depl~te LC from mous~ and human skin [10- 17]. By 
momtonng epidermal prohferatw n we have previously shown 
that. a topical cort J cos~ero 1d IS absorbed when it is topically 
apphed to a hum~n graft [8]. :£:lecause these agents can be given 
over t nne to grafts, t he expenments outlined in Tables II and 
III have been performed. Topical cort icosteroids (BY) did effect 
a decrease that 1s dose-dependent (see Table II) . Recovery 
follows th1s de~rease. Chang~s are more dramatic and sign ifi-
cant on analysis of LC density by Ia. Analysis has not been 
extended beyond day 16, in t hat the objective of t hese experi -
ments IS to deplete LC from the grafts . 
. Large doses (1200 mJ/cm2 ) of UVB (approximately 24-40 
tnnes a mimmal ~rythematous dose) delivered only to t l~ e grafts 
ove r a 6-day penod a lso effected a decrease in the number of 
LC (Table III) . Aga in , t here is recovery. By day 16, t he percen t 
of con tro_l values demo_nstrates a recovery to near normal by 
~ n a lys 1 s for A_TPase, t h1s does not occur un til day 24 by analysis 
for Ia. The figu res show LC have recovered relative to both 
density and dendritic processes. 
Ot her investigato rs have shown that cells bearing Ia can be 
depleted from epidermal cell suspensions with monospecific 
antise ra and complement [2,3]. T his prompted serious attempts 
to kd l t he LC jn t he STSG before transplantation. To destroy 
LC in t hinSTSG in a manner ana logous to that of t he test 
system, RaJ! ce lls (se~ Materials and Methods), t he STSG (0.2 
mm) are mcubated w1 th a 1:40 dilution of ant i-HLA-DR for 16 
h followed by a 20-min incubation with t he complement source 
and then e i th~ r held in vitro for 24 h at 3TC, 5% CO~, a nd 
complete med1a, and t ransplan ted, or transplanted immedi-
ately. Two weeks late r, these grafts are removed and ana lyzed 
for LC dens1ty usmg ATPase, anti-HLA-DR, and another 
monoclonal_ antibody, OKT-6, which ident ifies LC. In none of 
t hese_ expenments IS there any evidence of depletion of LC. 
A further attempt to d~plete. LC has been made ut ilizing the 
concept o_f spec1_1Jc target111g of a toxm (whole-chain ricin) to a 
se lected t issue v1a a monoclonal ant ibody. As noted in Materials 
and Met~ods, t hi s c_onjugate complex se lective ly kills t he test 
cells 111 vitro and bmds to t he LC of the STSG. Neither the 
ant1-HLA-DR alone nor t?e whole chain of ricin in t he presence 
of 200 mM galactose provides ev1dence of killing of ta rget cells. 
These SJ~ecJmens are also. ei th~r immediately t ransplanted or 
held 111 VItro for 48 h at 37 C pnor to tra nsplantation. Analys· -
fo_r LC density by ATPase, HLA-DR, and OKT-6 immediate !~ 
after t he 48- h mcubatwn, and at 3 weeks after t ransplantation 
shows no dec rease 111 the density of LC. The fa ilure to see a ' 
d . d . 
ny 
ecrease 111 ens1ty or any change in morphology at 3 weeks in 
any of t he ~orego111g caused us to abandon planned functional 
assays (antigen-presenting capacity) of LC. 
DISCUSSION 
Alt hough the objective whic h prompted these experiments-
depleting a functional skin of LC- has yet to be achieved t hese 
experiments do provide add itiona l insights into t he biol~gy of 
LC. T he demonstratio n b~ Katz et al and Frelinger et a!, t hat 
LC are of bone marrow on gm has been in terpreted as evidence 
t hat LC are not a stable resident population in t he epidermi . 
rather,. t hat LC derive from ci rculating ce lls t hat migrate in t~ 
t he skm [2,26,27]. The data in Table I suggest t hat the LC 
population is qui te stable in a situation where host mouse LC 
do not move into donor skin. The depletion data (see Tables II 
and III) support t he notion of a stable population, i.e. , when 
the graft is apparently depleted of LC, it is readily replenished 
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TABLE II. Betamethasone valerate to human skin grafts on nude mice, 0%, 0.1 %, .I % daily X 5: effects on marl~ers for Langerhans cells 
-
--
ATPase Ia 
Treatm ent 
---
n Mean no. LC/mm2 Percent control n Mean no. LC/mm2 Percent control 
Control day 2 6 383 ± 288 
BV 0.1 % day 2 5 259± 174" 
BV O.L % day 16 5 374 ± 168" 
BV 1.0% day 2 10 188 ± 188" 
BV 1.0% day 16 7 195 ± 76" 
" Values a re not s ignifi cantly diffe ren t from its cont rol. 
100 
62 
95 
31 
62 
6 
5 
5 
10 
8 
835 ± 178 
381 ± 161" 
534 ± 38b 
227 ± 1061' 
450 ± 1051' 
100 
46 
83 
27 
65 
1
' Va lues a re s ignifica ntly diffe ren t, p < 0.005, (t -test of means) from its cont rol. 
TABLE Ill. Ultraviolet radiation light (UVB) to human skin grafts 400 
mJ/ cm? every 48 h. X 3; effect on cell markers [or Langerlwns cells 
(x no. LC/mm? ± S D) 
ATPase Ia 
- --
x No. LC Percent x No. LC Percent n 
control n control 
Contro l 12 355 ± 113 100 9 537 ± 188 100 
1200 mJ /cm2 
Day 2 4 325 ± 60" 92 3 58± 53" 11 
Day 9 7 186 ± 941' 52 4 106 ± 126" 20 
Day 16 4 273 ± 76" 77 3 llO ± 331' 20 
Day 24 2 5 14 ± 13" 145 2 550 ± 148" 102 
" Values a re not significantly diffe rent from its control. 
• Values are s ignifica n t ly differen t p < 0.005 (l -test of means) when 
compared with its contro l. 
by hu man LC. Histologic assessment of t he de rmis of STSG 
before and afte r tra nsplantation reveals no change in the den-
~ i ty of dendri t ic HLA -DR positive cells within the dermis 
(numerous unpub lished observations). Whether LC divide lo-
ca lly and rep leni sh the skin fo llowing the insults ut ili zed for 
depletion or merely represent temporary loss of markers is 
unknown. 
T he li terature provides relatively weak support for a loca l 
repopu lation of LC. The limited studies examining the question 
use autoradiograp hic analysis of skin stimulated and not stim -
ulated to pro liferate (1 ,28- 31] . These analyses reveal a very 
low base line of pro li fe ration for LC in t he unstimulated epider-
mis. This tec hnology is somewhat limited in that a stimulated 
epidermis migh t promote DNA repair in a ll cells and, t hus, 
unless ["H] thymidine incorporation is seen with mitosis in LC 
it may not be related to mitos is and subsequent cell division . 
LC appea r to be capable of mitosi s. Recently, another electron 
micrograph has been published of a LC in mitosis. This con-
firms other simila r obse rvations of LC in mitosis, two of which 
are from samples of a basal cell carcinoma l32,33]. 
We fee l most of our data a re compatible with a loss of markers 
unique to LC and not the loss of LC with subsequent repl ace-
ment. This argument is based on the observation that the 
increases and decreases in the number of LC subsequent to the 
va ri ous t reatments a re disparate. Topical corticosteroids cause 
an apparent dec rease in the number of LC which is nea rly 
equivalent, Ia vs ATPase, at all t ime intervals and dosages 
tested. Cont ra ry are t he values for the UVB-treated grafts. At 
day 2, the number of LC by ATPase is 92% of control, whi le 
t he number by Ia analysis is on ly 11% of control. This contrasts 
wit h t he day 9 results where there is a further dec rease in the 
number of LC by ATPase, 52% of control, whi le the number 
by Ia ana lys is has started to normalize, 20% of cont rol - a 
decrease for ATPase and an increase for Ia. This type of 
fluctua t ion , a decrease by one marker and an increase by 
another marker, seems incompat ible with a loss of old LC and 
entry of new LC. Usually (see controls of Tables I, II, III), more 
LC are detected by Ia t han by ATPase. This s hould not imply 
that ATPase is a more lab ile marker; following treatment, t he 
percent of control for ATPase is generally greater than it is for 
la (see Tables II, III) . The data seem to support the notion that 
LC have differing states of differentiation and are different ially 
responsive to treatment protocol. 
Our observations of dec reases in the number of LC by 
A TPase and Ia after t he topical application of corticosteroids 
confirms t he in sit u effects on human skin by Berman et a l. 
They note, using an la marker analysis, t hat the twice da ily 
application of a fluorinated cort icosteroid for 10 days, reduced 
the number of LC to 26% of cont rol [17]. We saw similar 
decreases a fter applying BV for 5 days. They also showed that 
the topica l fluorinated corticoste roids did not permanently alter 
LC density. These authors reached this conclusion based upon 
anot her analysis of LC density, identifying LC with a non-Ia 
marker (the monoclonal antibody OKT-6) . This analysis 
showed only a 10% decrease in the number of LC following the 
topical application of corticosteroids. The only analysis we did 
in the UVB-treated group with OKT-6 came at day 24 where 
t he number of LC/mm1 by anti-HLA-DR and OKT-6 were 
equivalent. 
This report confirms the obse rvations of others that UVB 
decreases the expression of markers for LC [10- 15]. Because 
t he nude mouse system does not have circulating precursors 
for human LC, it goes one step further and demonstra tes that 
UVB does not permanen tly deplete LC or t heir precursors from 
the skin . The reason why our system requires such la rge dosages 
of UVB invoke the changes seen by other investigators with 
lower dosages is likely related to t he fac t that human skin 
transplanted to the nude mouse becomes more pigmented. After 
4 weeks of engraitment, it is unusual to have a gra ft t hat does 
not have skin color inherent to skin types 4 and 5 (personal 
obse rvations). 
The status of human LC relative to radiosensitivity is basi-
cally unknown. Experiments where mice have been lethally 
irradiated and then bone marrow reconstituted, demonstrate 
that wit hin several months, most of the new LC a re from the 
bone marrow donor. This suggests that the host LC and its 
precursors a re incapable of dividing, i.e., are at least somewhat 
radiosensitive l25,26]. X- irradiation of human skin with similar 
dosages prior to transplantation does lead to a decrease in the 
number of LC/mm2 . T ape-stripping this x-irracliated skin also 
decreases t he number of LC 24 h after treatment; however, 2 
weeks later the values are back to near normal, 560 mm2, a 
value very similar to the sham x-irradiated group. These data 
suggest that LC or at least its precursor is radiation-resistant. 
Reasons for the less than total depletion of LC by tape-
stripping are unknown, but might relate to t he fac t that the 
epidermis of human sk in transplanted to the nude mouse does 
become slightly th ickened. Generally, t he thickness of the 
epidermis of grafts increases from approximately 35 llm pre-
graft to as much as 4-5-50 11m post graft ing. However, increasing 
t he tape-stripping to 30 times, at which point the juncture 
between the mouse skin and human skin is devoid of epidermis 
and is bleeding freely, led to a similar but again on ly transient 
decrease in LC density. 
The toxin -conjugated and t he complement-mediated experi-
ments with the monoconal antibody HLA-DR confirm this 
technology as an effective means for in vitro depletion of 
contro l ce ll types bearing DR antigen, (Raji cells) . The failure 
of t his system to eliminate LC, especially with direct evidence 
June 1984 
of delivery to t he target, us in g immunodi agnostic reage n ts, 
s u ggest s t hat t he target antigen is shed , or t hat precursor cells 
without t his a n t igen a re ab le to replace t hi s injured/ ki lled L C. 
The fact t hat not eve n a temporary depletion in L C numbers 
h as been seen with t he toxi n-conjugated or complement-me-
diated toxicity studies, causes us to fee l that the failure at 
d ep letion migh t be secondary to a shedding of t hese a n t igens. 
In t hi s scen a rio t he a ttached a nt ibodies w it h complement or 
ricin would rem a in in t he immediate cell u lar environmen ts . 
The s hed a n t igen -a n t ibody tox in -toxin complex is t hen inca-
p ab le of deli vering t his desired toxic b low. This notion is 
s uppor ted by t he obse rvation of a n t i-I-:ILA-DR when t he sec-
o nd-step reagen t, goat antimouse, flu orescein labeled, was 
a dde d to a graft t hat. was removed 7 days after being on t he 
animal. This labeled seconda ry antibody bound to t he a nti -
BLA-DR t he combination of which outlined dendritic cell 
processes c ha racter istic of Langer ha ns ce lls. T~is is interpreted 
as indicati ng t hat t he monoclonal a ntibody wh1ch bound to t he 
LC prior to t ra nsp lantation is still within t he vic in ity of the 
target L C. Desp ite the a n t ibody be ing present for 7 days, there 
was no dec rease in the number of LC by a different assay, 
ATPase. 
The decrease in the number of LC over time, in t he never-
treated group (see Table I) is constant through approx imately 
the 8th wee k. T hereafter, a further decrease is not noted. A 
r ecent a na lysis (not pa rt of t hi s study) of skin engrafted for 
112 days (16 weeks) revea ls a mean nurnber of LC/mm 2 wh ich 
is n ea rly ide ntical to t hat of t he 9-wee:k data of T ab le I. Aged 
s kin is reported to have fewer LC/uni t area t han nonaged skin 
[ 15]. Howeve r, we have no evidence t hat t he decrease we see 
0 ver a s hort p eri od of t ime is analogous to _the agmg process .. It is possible t hat a ll of t he apparent disp!J ntles presen ted herem ,_ 
as well as t he disparity between our ob servatiOn s a nd t hose of 
oth e r in vestigato rs [26,27), is secondary to a subpopulation of 
LC t hat has vacated t he epidermis, and a nother popu latiOn 
t h at does not vacate t he epidermis. Al th ou <~h we have been unable to deplete LC from human 
skin grafted to nude mice, t his is a system from which, because 
h ost mouse L C wi ll not infil trate, much ca n be learned about 
regu lato ry mecha nis ms of t he migration of L C [9]. It app_ears 
t h at LC are curre nt ly e it her long- li ved o r replaced locally from 
a proliferative poo l, t hat certain cell m embrane determina n ts 
of human LC (ATPase a nd Ia- like molecules)_ a re somewhat 
differentia lly sensit ive to UV radiation ~nd cortJcosteroJ~s, and 
t h at huma n LC ap pea r to be relatively radwres1stant. Fma lly , 
it eems LC a re not eas ily dis lodged in an y perman~nt way 
which , at least in a te leo logic sense, SLlpports the notwn t hat 
LC a re criti ca l to s kin homeostas is. 
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